The Archive · 4 posts
Powering precision medicine 🎯 Genedrive PLC (GDR) is revolutionising genetic diagnostics on the LSE. Join the future of healthcare 🌟
Genedrive partners with Thermo Fisher to launch a high-throughput CYP2C19 test for NHS labs, expanding beyond point-of-care into centralised stroke care diagnostics.
June 29, 2026
Showing 3 of 4 posts
Genedrive secures £4.9m funding, eliminates debt, and gains NHS traction for rapid genetic tests, advancing US and international commercialisation.
JoshuaMarch 30, 2026
Genedrive's FY25 results show revenue doubled to £1.0m, but auditors flag a 'material uncertainty' over going concern due to severe cash pressure.
JoshuaDecember 5, 2025
Genedrive doubles FY25 revenue to £1m; strong FY26 visibility & NHS reforms to boost adoption of NICE-recommended point-of-care tests.
JoshuaAugust 11, 2025